NAT10 and melanoma: To further determine the effects of NAT10 on drug resistance of melanoma cells, we inhibited the expression of NAT10 using short-hairpin RNA (shRNA) and selected shRNA #2 for subsequent experiments due to its highest knockdown efficacy.